Amarantus Bioscience Holdings - 15 Year Stock Price History | AMBS
Historical daily share price chart and data for Amarantus Bioscience Holdings since 2010 adjusted for splits and dividends. The latest closing stock price for Amarantus Bioscience Holdings as of August 07, 2025 is 0.00.
- The all-time high Amarantus Bioscience Holdings stock closing price was 225.00 on June 14, 2011.
- The Amarantus Bioscience Holdings 52-week high stock price is 0.04, which is % above the current share price.
- The Amarantus Bioscience Holdings 52-week low stock price is 0.00, which is % below the current share price.
- The average Amarantus Bioscience Holdings stock price for the last 52 weeks is 0.00.
| Amarantus Bioscience Holdings Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 0.0003 | 0.0001 | 0.0005 | 0.0000 | 0.0003 | 0.00% |
| 2024 | 0.0002 | 0.0010 | 0.0015 | 0.0000 | 0.0000 | -100.00% |
| 2023 | 0.0010 | 0.0014 | 0.0019 | 0.0005 | 0.0005 | -70.59% |
| 2022 | 0.0052 | 0.0157 | 0.0157 | 0.0012 | 0.0017 | -89.63% |
| 2021 | 0.0093 | 0.0090 | 0.0165 | 0.0046 | 0.0164 | 105.00% |
| 2020 | 0.0101 | 0.0105 | 0.0213 | 0.0045 | 0.0080 | -38.93% |
| 2019 | 0.0223 | 0.0218 | 0.0439 | 0.0119 | 0.0131 | -34.50% |
| 2018 | 0.0468 | 0.1370 | 0.1370 | 0.0160 | 0.0200 | -85.82% |
| 2017 | 0.0406 | 0.0270 | 0.1800 | 0.0212 | 0.1410 | 426.12% |
| 2016 | 0.0880 | 0.6600 | 0.6600 | 0.0225 | 0.0268 | -95.78% |
| 2015 | 5.5558 | 12.3000 | 14.7750 | 0.2750 | 0.6350 | -94.85% |
| 2014 | 14.0851 | 10.6500 | 29.0250 | 9.6900 | 12.3300 | 3.01% |
| 2013 | 8.6026 | 25.8000 | 25.8000 | 4.3500 | 11.9700 | -39.55% |
| 2012 | 6.8559 | 16.5000 | 21.0000 | 0.6450 | 19.8000 | -2.22% |
| 2011 | 38.6112 | 11.7000 | 225.0000 | 9.0000 | 20.2500 | 3275.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $0.000B |
| Amarantus BioScience, Inc. is a biotechnology company. It focuses on discovering and developing treatments and diagnostics for diseases associated with protein misfolding and apoptosis centered around its patented therapeutic protein Mesencephalic Astrocyte-derived Neurotrophic Factor. Amarantus BioScience, Inc. is based in Sunnyvale, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.611B | 26.64 |
| CVS Health (CVS) | United States | $83.126B | 10.34 |
| Elevance Health (ELV) | United States | $66.200B | 8.90 |
| Cencora (COR) | United States | $55.265B | 18.41 |
| DiDi Global (DIDIY) | China | $26.074B | 27.70 |
| Labcorp Holdings (LH) | United States | $22.092B | 17.56 |
| Natera (NTRA) | United States | $20.748B | 0.00 |
| BioMerieux (BMXMF) | France | $17.652B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.860B | 0.00 |
| CochLear (CHEOY) | Australia | $13.234B | 0.00 |
| ICON (ICLR) | Ireland | $12.795B | 12.31 |
| Solventum (SOLV) | United States | $12.697B | 13.13 |
| Medpace Holdings (MEDP) | United States | $12.202B | 32.29 |
| Viatris (VTRS) | United States | $11.385B | 4.02 |
| Revvity (RVTY) | United States | $10.080B | 17.76 |
| Sonic Healthcare (SKHHY) | Australia | $8.961B | 0.00 |
| HealthEquity (HQY) | United States | $8.047B | 35.25 |
| Avantor (AVTR) | United States | $7.840B | 11.50 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.569B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.320B | 13.89 |
| Bausch + Lomb (BLCO) | Canada | $4.828B | 32.48 |
| Sotera Health (SHC) | United States | $3.965B | 22.17 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| BrightSpring Health Services (BTSG) | United States | $3.681B | 28.08 |
| Surgery Partners (SGRY) | United States | $3.031B | 38.13 |
| GeneDx Holdings (WGS) | United States | $3.020B | 69.16 |
| Alignment Healthcare (ALHC) | United States | $2.873B | 0.00 |
| Concentras Parent (CON) | United States | $2.771B | 17.58 |
| Organon (OGN) | United States | $2.397B | 2.61 |
| Progyny (PGNY) | United States | $1.959B | 41.54 |
| Premier (PINC) | United States | $1.921B | 14.58 |
| Ardent Health (ARDT) | United States | $1.702B | 6.57 |
| PACS (PACS) | United States | $1.698B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.248B | 8.33 |
| GoodRx Holdings (GDRX) | United States | $1.239B | 20.41 |
| Teladoc Health (TDOC) | United States | $1.230B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.008B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Embecta (EMBC) | United States | $0.718B | 4.21 |
| AMN Healthcare Services Inc (AMN) | United States | $0.660B | 8.17 |
| CareDx (CDNA) | United States | $0.637B | 11.73 |
| Performant Healthcare (PHLT) | United States | $0.602B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.586B | 201.00 |
| So-Young (SY) | China | $0.506B | 0.00 |
| Omada Health (OMDA) | $0.490B | 0.00 | |
| Nutex Health (NUTX) | United States | $0.488B | 7.39 |
| Auna S.A (AUNA) | Luxembourg | $0.460B | 10.37 |
| Sonida Senior Living (SNDA) | United States | $0.460B | 0.00 |
| SBC Medicals (SBC) | United States | $0.456B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.447B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.421B | 0.00 |
| Enhabit (EHAB) | United States | $0.386B | 25.40 |
| Oncology Institute (TOI) | United States | $0.382B | 0.00 |
| Agilon Health (AGL) | United States | $0.362B | 0.00 |
| LifeMD (LFMD) | United States | $0.323B | 0.00 |
| Beauty Health (SKIN) | United States | $0.238B | 0.00 |
| Shoulder Innovations (SI) | $0.189B | 0.00 | |
| DocGo (DCGO) | United States | $0.160B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.106B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.093B | 0.00 |
| KindlyMD (NAKA) | United States | $0.073B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Biodesix (BDSX) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| ModivCare (MODV) | United States | $0.035B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |